Last 32,700 KRW
Change Today +450.00 / 1.40%
Volume 135.7K
068870 On Other Exchanges
Symbol
Exchange
Korea SE
Korea SE
As of 2:24 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

lg life sciences ltd (068870) Snapshot

Open
32,550
Previous Close
32,250
Day High
32,850
Day Low
32,150
52 Week High
08/5/13 - 58,700
52 Week Low
07/14/14 - 31,100
Market Cap
542.1B
Average Volume 10 Days
123.9K
EPS TTM
80.00
Shares Outstanding
16.6M
EX-Date
--
P/E TM
408.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for LG LIFE SCIENCES LTD (068870)

Related News

No related news articles were found.

lg life sciences ltd (068870) Related Businessweek News

No Related Businessweek News Found

lg life sciences ltd (068870) Details

LG Life Sciences Co, Ltd. researches, develops, produces, and sells pharmaceuticals, animal health products, and specialty chemicals in South Korea and internationally. Its pharmaceutical products include Eutravac and Euforvac vaccines for diphtheria, tetanus, acellular and whole cell pertussis, and r-DNA hepatitis B; Follitrope, a follicle stimulating hormone; Euvax B vaccine against infection caused by various subtypes of hepatitis B virus; LG influenza HA vaccine against influenza virus type A and type B; and LG DTaP vaccine for diphtheria, tetanus, and aceulluar Pertussis infection. The company also provides Espogen, a drug for anemia in patients with chronic renal failure; cardiovascular drugs, such as Xilep XL, Novamet GR, Zanidip, Acecol, Calvan, LG Enalapril, and LG Cilastasol; Eutropin, an endocrine drug; and anti-infective drugs, including Factive, Intermax-Alpha, Cefatame, LG Ceftriaxone, Tarocef, and Ribavirin. In addition, it offers Hyruan and Hyruan Plus for the osteoarthritis of knees and shoulder periarthritis; Hyal 2000 and Hyal Plus that are used during surgical procedures on the eyes; YVOIRE for the correction of facial wrinkles and folds; and Protescal for the reduction of post-surgical adhesion. Its oncology drugs consist of Intermax Gamma, LG Megestrol, and LG Tumercide; and infertility drugs include Follitrope, IVF-M, IVF-C, and Follimon; and specialty chemicals consist of crop protection products, such as insecticides, fungicides, herbicides, and pest management products, as well as active pharmaceutical intermediates. The company’s animal health products consist of Boostin-S and Boostin-250, which are milk production stimulants; and diagnostics products comprise ELISA kits; Real-time PCR kits; GenoBlot kits; and allergy screening system. LG Life Sciences, Ltd. is headquartered in Seoul, South Korea.

lg life sciences ltd (068870) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lg life sciences ltd (068870) Key Developments

LG Life Sciences, Ltd., Annual General Meeting, Mar 14, 2014

LG Life Sciences, Ltd., Annual General Meeting, Mar 14, 2014., at 10:30 Korea Standard Time. Location: Jongno-newspaper 2 LG Gwanghwamun, the base of the building, second floor auditorium. Agenda: To consider the 12th (2013) financial statements (statement of retained earnings (not)), and approval of the consolidated financial statements; to consider some change in constitution; tpo consider the election of directors; to appoint Audit Committee; and to consider the approval of director remuneration.

LG Life Sciences Not To Acquire Aminologics

LG Life Sciences, Ltd. (KOSE:A068870) has denied the rumors that it is planning to acquire Aminologics Co., Ltd. (KOSE:A074430).

LG Life Sciences Signs Licensing Deal with Stendhal for Development and Commercialisation of Two Diabetes Drugs in Central and South America

LG Life Sciences has signed a licensing deal with Stendhal for development and commercialisation of two diabetes drugs in Central and South America. Stendhal will have exclusive rights to develop the LG-developed dipeptidyl peptidase-4 (DPP-IV) inhibitors Zemiglo (gemigliptin) and ZemiMet (gemigliptin + metformin) in 23 countries in the region, including Mexico, Colombia, and Venezuela, in return for upfront payments and sales royalties.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
068870:KS 32,700.00 KRW +450.00

068870 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 068870.
View Industry Companies
 

Industry Analysis

068870

Industry Average

Valuation 068870 Industry Range
Price/Earnings 100.0x
Price/Sales 1.4x
Price/Book 2.3x
Price/Cash Flow 105.7x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LG LIFE SCIENCES LTD, please visit www.lgls.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.